MeSH Browser

MeSH Heading: Atazanavir Sulfate
Tree Number(s): D03.383.725.068; D12.644.456.157
Unique ID: D000069446
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000069446
Scope Note: An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.
Entry Term(s): 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester; Atazanavir; BMS 232632; BMS-232632; BMS-232632-05; BMS232632; CGP 73547; CGP 75136; CGP 75176; CGP 75355; CGP-73547; CGP-75136; CGP-75176; CGP-75355; CGP75136; CGP75176; CGP75355; Reyataz
Pharm Action: HIV Protease Inhibitors
Registry Numbers: 4MT4VIE29P; 0; QZU4H47A3S
Related Numbers: 229975-97-7; QZU4H47A3S
Public MeSH Note: 2016; ATAZANAVIR SULFATE was indexed under OLIGOPEPTIDES and PYRIDINES 2000-2015
History Note: 2016 (2000)
Date Established: 2016/01/01
Date of Entry: 2015/07/09
Revision Date: 2016/07/11

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Atazanavir Sulfate MeSH Descriptor Data 2025